{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:25:48Z","timestamp":1793406348658,"version":"4.5.0"},"reference-count":158,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Hepatocellular carcinoma (HCC) is a common liver malignancy with high morbidity and poor prognosis. Long non-coding RNAs (lncRNAs) are involved in crucial biological processes of tumorigenesis and progression, and play four major regulatory roles, namely signal, decoy, guide, and scaffold, to regulate gene expression. Through these processes, lncRNAs can target microRNAs (miRNAs) to form lncRNA and miRNA networks, which regulate cancer cell proliferation, metastasis, drug resistance, and the tumor microenvironment. Here, we summarize the multifaceted functions of lncRNA and miRNA networks in the pathogenesis of HCC, the potential use of diagnostic or prognostic biomarkers, and novel therapeutic targets in HCC. This review also highlights the regulatory effects of lncRNA and miRNA networks in the tumor microenvironment of HCC.<\/jats:p>","DOI":"10.3390\/ijms221910630","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T10:55:40Z","timestamp":1633085740000},"page":"10630","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["The Role of Long Non-Coding RNA and microRNA Networks in Hepatocellular Carcinoma and Its Tumor Microenvironment"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9852-6961","authenticated-orcid":false,"given":"Tingting","family":"Shi","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0760-3045","authenticated-orcid":false,"given":"Asahiro","family":"Morishita","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8508-827X","authenticated-orcid":false,"given":"Hideki","family":"Kobara","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Masaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: Trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Roehlen, N., Crouchet, E., and Baumert, T.F. (2020). Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells, 9.","DOI":"10.3390\/cells9040875"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/JHC.S274933","article-title":"Mechanisms Underlying Hepatocellular Carcinoma Progression in Patients with Type 2 Diabetes","volume":"8","author":"Shi","year":"2021","journal-title":"J. Hepatocell Carcinoma"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: A randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/hep.24710","article-title":"Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992\u20132008","volume":"55","author":"Altekruse","year":"2012","journal-title":"Hepatology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev.pathol.4.110807.092222","article-title":"MicroRNAs in cancer","volume":"4","author":"Lee","year":"2009","journal-title":"Annu. Rev. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbrc.2006.07.207","article-title":"Human microRNA clusters: Genomic organization and expression profile in leukemia cell lines","volume":"349","author":"Yu","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.mrrev.2019.05.005","article-title":"The role of miRNAs as biomarkers in prostate cancer","volume":"781","author":"Cozar","year":"2019","journal-title":"Mutat. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41556-019-0311-8","article-title":"Cellular functions of long noncoding RNAs","volume":"21","author":"Yao","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Chi, Y., Wang, D., Wang, J., Yu, W., and Yang, J. (2019). Long Non-Coding RNA in the Pathogenesis of Cancers. Cells, 8.","DOI":"10.3390\/cells8091015"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nature10887","article-title":"Modular regulatory principles of large non-coding RNAs","volume":"482","author":"Guttman","year":"2012","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.molcel.2011.08.018","article-title":"Molecular mechanisms of long noncoding RNAs","volume":"43","author":"Wang","year":"2011","journal-title":"Mol. Cell"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Cheng, J.T., Wang, L., Wang, H., Tang, F.R., Cai, W.Q., Sethi, G., Xin, H.W., and Ma, Z. (2019). Insights into Biological Role of LncRNAs in Epithelial-Mesenchymal Transition. Cells, 8.","DOI":"10.3390\/cells8101178"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0219-1","article-title":"Exploiting the message from cancer: The diagnostic value of extracellular vesicles for clinical applications","volume":"51","author":"Kosaka","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/hep.30793","article-title":"Long Noncoding RNA p53-Stabilizing and Activating RNA Promotes p53 Signaling by Inhibiting Heterogeneous Nuclear Ribonucleoprotein K deSUMOylation and Suppresses Hepatocellular Carcinoma","volume":"71","author":"Qin","year":"2020","journal-title":"Hepatology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1136\/gutjnl-2019-319637","article-title":"Hepatitis B protein HBx binds the DLEU2 lncRNA to sustain cccDNA and host cancer-related gene transcription","volume":"69","author":"Salerno","year":"2020","journal-title":"Gut"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41419-021-03453-w","article-title":"Identification of a long non-coding RNA regulator of liver carcinoma cell survival","volume":"12","author":"Rybakova","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.addr.2015.05.012","article-title":"Basic biology and therapeutic implications of lncRNA","volume":"87","author":"Khorkova","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Fernandes, J.C.R., Acu\u00f1a, S.M., Aoki, J.I., Floeter-Winter, L.M., and Muxel, S.M. (2019). Long Non-Coding RNAs in the Regulation of Gene Expression: Physiology and Disease. Noncoding RNA, 5.","DOI":"10.3390\/ncrna5010017"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.canlet.2014.12.051","article-title":"Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152","volume":"359","author":"Yao","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Morishita, A., Oura, K., Tadokoro, T., Fujita, K., Tani, J., and Masaki, T. (2021). MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review. Cancers, 13.","DOI":"10.3390\/cancers13030514"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"G559","DOI":"10.1152\/ajpgi.00242.2017","article-title":"lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214","volume":"314","author":"Huang","year":"2018","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.18632\/aging.102240","article-title":"lncRNA miat functions as a ceRNA to upregulate sirt1 by sponging miR-22-3p in HCC cellular senescence","volume":"11","author":"Zhao","year":"2019","journal-title":"Aging"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-019-0957-7","article-title":"A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p\/FOXA1 axis","volume":"18","author":"Wang","year":"2019","journal-title":"Mol. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12943-017-0680-1","article-title":"STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4","volume":"16","author":"Wang","year":"2017","journal-title":"Mol. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12943-017-0676-x","article-title":"The noncoding RNA HOXD-AS1 is a critical regulator of the metastasis and apoptosis phenotype in human hepatocellular carcinoma","volume":"16","author":"Lu","year":"2017","journal-title":"Mol. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1038\/onc.2016.521","article-title":"LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells","volume":"36","author":"Xiong","year":"2017","journal-title":"Oncogene"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.18632\/aging.101645","article-title":"LncRNA CDKN2BAS predicts poor prognosis in patients with hepatocellular carcinoma and promotes metastasis via the miR-153-5p\/ARHGAP18 signaling axis","volume":"10","author":"Chen","year":"2018","journal-title":"Aging"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.lfs.2018.02.006","article-title":"LncRNA FAL1 promotes cell proliferation and migration by acting as a CeRNA of miR-1236 in hepatocellular carcinoma cells","volume":"197","author":"Li","year":"2018","journal-title":"Life Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ccr.2014.03.010","article-title":"A long noncoding RNA activated by TGF-\u03b2 promotes the invasion-metastasis cascade in hepatocellular carcinoma","volume":"25","author":"Yuan","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/1878-0261.12606","article-title":"Long noncoding RNA LINC00662 promotes M2 macrophage polarization and hepatocellular carcinoma progression via activating Wnt\/\u03b2-catenin signaling","volume":"14","author":"Tian","year":"2020","journal-title":"Mol. Oncol."},{"key":"ref_33","first-page":"583","article-title":"LncRNA FLJ33360 accelerates the metastasis in hepatocellular carcinoma by targeting miRNA-140\/MMP9 axis","volume":"12","author":"Lu","year":"2020","journal-title":"Am. J. Transl. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13045-019-0839-x","article-title":"M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma","volume":"13","author":"Zuo","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1002\/jcp.27095","article-title":"LncRNA SNHG3 induces EMT and sorafenib resistance by modulating the miR-128\/CD151 pathway in hepatocellular carcinoma","volume":"234","author":"Zhang","year":"2019","journal-title":"J. Cell Physiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.canlet.2019.11.001","article-title":"Macrophages-induced long noncoding RNA H19 up-regulation triggers and activates the miR-193b\/MAPK1 axis and promotes cell aggressiveness in hepatocellular carcinoma","volume":"469","author":"Ye","year":"2020","journal-title":"Cancer Lett."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1158\/0008-5472.CAN-17-1915","article-title":"Mesenchymal Stem Cells Promote Hepatocarcinogenesis via lncRNA-MUF Interaction with ANXA2 and miR-34a","volume":"77","author":"Yan","year":"2017","journal-title":"Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12943-018-0838-5","article-title":"Long non-coding RNA NEAT1-modulated abnormal lipolysis via ATGL drives hepatocellular carcinoma proliferation","volume":"17","author":"Liu","year":"2018","journal-title":"Mol. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e12628","DOI":"10.1111\/cpr.12628","article-title":"DANCR promotes HCC progression and regulates EMT by sponging miR-27a-3p via ROCK1\/LIMK1\/COFILIN1 pathway","volume":"52","author":"Guo","year":"2019","journal-title":"Cell Prolif."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/hep.27893","article-title":"Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma by derepression of CTNNB1","volume":"63","author":"Yuan","year":"2016","journal-title":"Hepatology"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Li, Z., Wu, G., Li, J., Wang, Y., Ju, X., and Jiang, W. (2020). lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC. BMC Cancer, 20.","DOI":"10.1186\/s12885-020-06771-y"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s13046-019-1188-x","article-title":"Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma","volume":"38","author":"Liu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.canlet.2018.08.024","article-title":"LncRNA CDKN2B-AS1 promotes tumor growth and metastasis of human hepatocellular carcinoma by targeting let-7c-5p\/NAP1L1 axis","volume":"437","author":"Huang","year":"2018","journal-title":"Cancer Lett."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"119288","DOI":"10.1016\/j.lfs.2021.119288","article-title":"LncRNA BACE1-AS enhances the invasive and metastatic capacity of hepatocellular carcinoma cells through mediating miR-377-3p\/CELF1 axis","volume":"275","author":"Liu","year":"2021","journal-title":"Life Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2147\/OTT.S237161","article-title":"LncRNA SNHG11 Promotes Proliferation, Migration, Apoptosis, and Autophagy by Regulating hsa-miR-184\/AGO2 in HCC","volume":"13","author":"Huang","year":"2020","journal-title":"Onco. Targets Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.omtn.2019.10.007","article-title":"Silencing Long Non-coding RNA LINC01224 Inhibits Hepatocellular Carcinoma Progression via MicroRNA-330-5p-Induced Inhibition of CHEK1","volume":"19","author":"Gong","year":"2020","journal-title":"Mol. Ther. Nucleic. Acids"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1111\/cas.14631","article-title":"Long noncoding RNA PICSAR\/miR-588\/EIF6 axis regulates tumorigenesis of hepatocellular carcinoma by activating PI3K\/AKT\/mTOR signaling pathway","volume":"111","author":"Liu","year":"2020","journal-title":"Cancer Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13046-020-01739-z","article-title":"LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p\/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma","volume":"39","author":"Teng","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.bbrc.2020.09.115","article-title":"LncRNA ST8SIA6-AS1 promotes hepatocellular carcinoma progression by regulating MAGEA3 and DCAF4L2 expression","volume":"533","author":"Zhang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"7637","DOI":"10.1111\/jcmm.15399","article-title":"SNHG16\/miR-605-3p\/TRAF6\/NF-\u03baB feedback loop regulates hepatocellular carcinoma metastasis","volume":"24","author":"Hu","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bbrc.2019.10.105","article-title":"lncRNA OSER1-AS1 acts as a ceRNA to promote tumorigenesis in hepatocellular carcinoma by regulating miR-372-3p\/Rab23 axis","volume":"521","author":"Fan","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"10544","DOI":"10.18632\/aging.103278","article-title":"Long noncoding RNA LINC00460 conduces to tumor growth and metastasis of hepatocellular carcinoma through miR-342-3p-dependent AGR2 up-regulation","volume":"12","author":"Hong","year":"2020","journal-title":"Aging"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"BSR20192697","DOI":"10.1042\/BSR20192697","article-title":"LncRNA LINC00668 promotes cell proliferation, migration, invasion ability and EMT process in hepatocellular carcinoma by targeting miR-532-5p\/YY1 axis","volume":"40","author":"Xuan","year":"2020","journal-title":"Biosci. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.7150\/jca.29213","article-title":"LncRNA MALAT1 acts as a miR-125a-3p sponge to regulate FOXM1 expression and promote hepatocellular carcinoma progression","volume":"10","author":"Liu","year":"2019","journal-title":"J. Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1080\/15384101.2018.1464834","article-title":"LINC00152 promotes cell cycle progression in hepatocellular carcinoma via miR-193a\/b-3p\/CCND1 axis","volume":"17","author":"Ma","year":"2018","journal-title":"Cell Cycle"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12943-017-0702-z","article-title":"Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2\/miR-367\/FBXW7 axis","volume":"16","author":"Wang","year":"2017","journal-title":"Mol. Cancer"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13046-019-1128-9","article-title":"Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1","volume":"38","author":"Wang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"6154","DOI":"10.1002\/jcp.29544","article-title":"Long noncoding RNA TCL6 binds to miR-106a-5p to regulate hepatocellular carcinoma cells through PI3K\/AKT signaling pathway","volume":"235","author":"Luo","year":"2020","journal-title":"J. Cell Physiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.2147\/OTT.S289198","article-title":"m6A-Induced LncRNA MEG3 Suppresses the Proliferation, Migration and Invasion of Hepatocellular Carcinoma Cell Through miR-544b\/BTG2 Signaling","volume":"14","author":"Wu","year":"2021","journal-title":"Onco Targets"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"18825","DOI":"10.1002\/jcp.28521","article-title":"LncRNA MAGI2-AS3 inhibits hepatocellular carcinoma cell proliferation and migration by targeting the miR-374b-5p\/SMG1 signaling pathway","volume":"234","author":"Yin","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"G116","DOI":"10.1152\/ajpgi.00005.2019","article-title":"LINC01018 confers a novel tumor suppressor role in hepatocellular carcinoma through sponging microRNA-182-5p","volume":"317","author":"Wang","year":"2019","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/jcp.26779","article-title":"LncRNA DGCR5 represses the development of hepatocellular carcinoma by targeting the miR-346\/KLF14 axis","volume":"234","author":"Wang","year":"2018","journal-title":"J. Cell Physiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s13046-018-0853-9","article-title":"Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression","volume":"37","author":"Yan","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Lin, S.L., Lin, Y.H., Chi, H.C., Lin, T.K., Chen, W.J., Yeh, C.T., and Lin, K.H. (2020). A Novel Long Non-Coding RNA-01488 Suppressed Metastasis and Tumorigenesis by Inducing miRNAs That Reduce Vimentin Expression and Ubiquitination of Cyclin, E. Cells, 9.","DOI":"10.3390\/cells9061504"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.biocel.2017.09.008","article-title":"Long non-coding RNA 657 suppresses hepatocellular carcinoma cell growth by acting as a molecular sponge of miR-106a-5p to regulate PTEN expression","volume":"92","author":"Hu","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"11429","DOI":"10.1007\/s13277-016-4892-6","article-title":"Long non-coding RNA TUSC7 acts a molecular sponge for miR-10a and suppresses EMT in hepatocellular carcinoma","volume":"37","author":"Wang","year":"2016","journal-title":"Tumour. Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/cas.13950","article-title":"LncRNA MIR22HG inhibits growth, migration and invasion through regulating the miR-10a-5p\/NCOR2 axis in hepatocellular carcinoma cells","volume":"110","author":"Wu","year":"2019","journal-title":"Cancer Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13045-020-00937-8","article-title":"EZH2: A novel target for cancer treatment","volume":"13","author":"Duan","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"7087","DOI":"10.2147\/CMAR.S297765","article-title":"TGF-\u03b2-MTA1-SMAD7-SMAD3-SOX4-EZH2 Signaling Axis Promotes Viability, Migration, Invasion and EMT of Hepatocellular Carcinoma Cells","volume":"13","author":"Zhang","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Kotiyal, S., and Evason, K.J. (2021). Exploring the Interplay of Telomerase Reverse Transcriptase and \u03b2-Catenin in Hepatocellular Carcinoma. Cancers, 13.","DOI":"10.3390\/cancers13164202"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/jcb.29206","article-title":"Silencing of long noncoding RNA HOXD-AS1 inhibits proliferation, cell cycle progression, migration and invasion of hepatocellular carcinoma cells through MEK\/ERK pathway","volume":"121","author":"Sun","year":"2020","journal-title":"J. Cell Biochem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"5417598","DOI":"10.1155\/2020\/5417598","article-title":"A Circulating Long Noncoding RNA Panel Serves as a Diagnostic Marker for Hepatocellular Carcinoma","volume":"2020","author":"Huang","year":"2020","journal-title":"Dis. Markers"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.canlet.2019.04.008","article-title":"Long non-coding RNA HULC activates HBV by modulating HBx\/STAT3\/miR-539\/APOBEC3B signaling in HBV-related hepatocellular carcinoma","volume":"454","author":"Liu","year":"2019","journal-title":"Cancer Lett."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"42431","DOI":"10.18632\/oncotarget.9883","article-title":"LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p\/ZEB1 signaling pathway","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1158\/0008-5472.CAN-18-1432","article-title":"Long Noncoding RNA MALAT1 Regulates Cancer Glucose Metabolism by Enhancing mTOR-Mediated Translation of TCF7L2","volume":"79","author":"Malakar","year":"2019","journal-title":"Cancer Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.18632\/oncotarget.3219","article-title":"Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1\/ERK signaling pathway","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1089\/dna.2019.4882","article-title":"Overexpression of CASC2 Improves Cisplatin Sensitivity in Hepatocellular Carcinoma Through Sponging miR-222","volume":"38","author":"Liu","year":"2019","journal-title":"DNA Cell Biol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1159\/000452582","article-title":"Down-Regulation of LncRNA DGCR5 Correlates with Poor Prognosis in Hepatocellular Carcinoma","volume":"40","author":"Huang","year":"2016","journal-title":"Cell Physiol. Biochem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jhep.2016.01.005","article-title":"Salt-inducible Kinase (SIK1) regulates HCC progression and WNT\/\u03b2-catenin activation","volume":"64","author":"Qu","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.7150\/thno.22493","article-title":"Identification and Functional Characterization of Long Non-coding RNA MIR22HG as a Tumor Suppressor for Hepatocellular Carcinoma","volume":"8","author":"Zhang","year":"2018","journal-title":"Theranostics"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"572585","DOI":"10.3389\/fonc.2021.572585","article-title":"lncRNA MIR22HG-Derived miR-22-5p Enhances the Radiosensitivity of Hepatocellular Carcinoma by Increasing Histone Acetylation Through the Inhibition of HDAC2 Activity","volume":"11","author":"Jin","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jhep.2019.08.025","article-title":"Epidemiology and surveillance for hepatocellular carcinoma: New trends","volume":"72","author":"Singal","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1053\/j.gastro.2018.01.064","article-title":"Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis","volume":"154","author":"Tzartzeva","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00432-004-0552-0","article-title":"Randomized controlled trial of screening for hepatocellular carcinoma","volume":"130","author":"Zhang","year":"2004","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"BSR20171359","DOI":"10.1042\/BSR20171359","article-title":"Identification of long non-coding RNA ZFAS1 as a novel biomarker for diagnosis of HCC","volume":"38","author":"Luo","year":"2018","journal-title":"Biosci. Rep."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1002\/1878-0261.12745","article-title":"Serum small extracellular vesicle-derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma","volume":"14","author":"Kim","year":"2020","journal-title":"Mol. Oncol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"110111","DOI":"10.1016\/j.biopha.2020.110111","article-title":"RNA sequencing reveals the long noncoding RNA and mRNA profiles and identifies long non-coding RNA TSPAN12 as a potential microvascular invasion-related biomarker in hepatocellular carcinoma","volume":"126","author":"Lu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.clinthera.2020.01.012","article-title":"Correlation of Long Noncoding RNA SEMA6A-AS1 Expression with Clinical Outcome in HBV-Related Hepatocellular Carcinoma","volume":"42","author":"Yu","year":"2020","journal-title":"Clin. Ther."},{"key":"ref_90","first-page":"4008","article-title":"Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis","volume":"8","author":"Shi","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.trsl.2015.10.002","article-title":"Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma","volume":"168","author":"Kamel","year":"2016","journal-title":"Transl. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.biopha.2015.04.014","article-title":"Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma","volume":"72","author":"Peng","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/hep.26740","article-title":"Long noncoding RNA HOTTIP\/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients","volume":"59","author":"Quagliata","year":"2014","journal-title":"Hepatology"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.7150\/jca.24978","article-title":"Serum and exosome long non coding RNAs as potential biomarkers for hepatocellular carcinoma","volume":"9","author":"Sun","year":"2018","journal-title":"J. Cancer"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.7150\/jca.56340","article-title":"Highly deregulated lncRNA LOC is associated with overall worse prognosis in Hepatocellular Carcinoma patients","volume":"12","author":"Lim","year":"2021","journal-title":"J. Cancer"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.2147\/OTT.S254455","article-title":"A Novel lncRNA NONHSAT053785 Acts as an Independent Risk Factor for Intrahepatic Metastasis of Hepatocellular Carcinoma","volume":"13","author":"Li","year":"2020","journal-title":"Onco Targets"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"44050","DOI":"10.18632\/oncotarget.17211","article-title":"Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasis","volume":"8","author":"Guo","year":"2017","journal-title":"Oncotarget"},{"key":"ref_98","first-page":"5353695","article-title":"Circulating MicroRNA-122 for the Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis","volume":"2020","author":"Zhao","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jceh.2018.07.005","article-title":"Expression Analysis of MicroRNA-21 and MicroRNA-122 in Hepatocellular Carcinoma","volume":"9","author":"Bharali","year":"2019","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2478\/jtim-2020-0006","article-title":"MiR-155 and MiR-665 Role as Potential Non-invasive Biomarkers for Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection","volume":"8","author":"Mohamed","year":"2020","journal-title":"J. Transl. Int. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.clinre.2018.12.008","article-title":"Identification of plasma miR-148a as a noninvasive biomarker for hepatocellular carcinoma","volume":"43","author":"Han","year":"2019","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Cho, H.J., Eun, J.W., Baek, G.O., Seo, C.W., Ahn, H.R., Kim, S.S., Cho, S.W., and Cheong, J.Y. (2020). Serum Exosomal MicroRNA, miR-10b-5p, as a Potential Diagnostic Biomarker for Early-Stage Hepatocellular Carcinoma. J. Clin. Med., 9.","DOI":"10.3390\/jcm9010281"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1002\/ijc.29999","article-title":"Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma","volume":"138","author":"Ghosh","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_104","unstructured":"Yang, C., Du, P., and Lu, W. (2021). MiR-424 Acts as a Novel Biomarker in the Diagnosis of Patients with Hepatocellular Carcinoma. Cancer Biother. Radiopharm., 34287021."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.dld.2018.12.011","article-title":"Circulating microRNAs for the diagnosis of hepatocellular carcinoma","volume":"51","author":"Peng","year":"2019","journal-title":"Dig. Liver Dis."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Lurje, I., Czigany, Z., Bednarsch, J., Roderburg, C., Isfort, P., Neumann, U.P., and Lurje, G. (2019). Treatment Strategies for Hepatocellular Carcinoma -a Multidisciplinary Approach. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061465"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Song, W., Zheng, C., Liu, M., Xu, Y., Qian, Y., Zhang, Z., Su, H., Li, X., Wu, H., and Gong, P. (2021). TRERNA1 upregulation mediated by HBx promotes sorafenib resistance and cell proliferation in HCC via targeting NRAS by sponging miR-22-3p. Mol. Ther.","DOI":"10.1016\/j.ymthe.2021.04.011"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"111030","DOI":"10.1016\/j.biopha.2020.111030","article-title":"LncRNA TTN-AS1 intensifies sorafenib resistance in hepatocellular carcinoma by sponging miR-16-5p and upregulation of cyclin E1","volume":"133","author":"Zhou","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_109","first-page":"1794","article-title":"KCNQ1OT1 contributes to sorafenib resistance and programmed death-ligand-1-mediated immune escape via sponging miR-506 in hepatocellular carcinoma cells","volume":"46","author":"Zhang","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/jcb.29844","article-title":"lncRNA-POIR promotes epithelial-mesenchymal transition and suppresses sorafenib sensitivity simultaneously in hepatocellular carcinoma by sponging miR-182-5p","volume":"122","author":"Chen","year":"2021","journal-title":"J. Cell Biochem."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3892\/or.2020.7608","article-title":"Long non-coding RNA H19 is involved in sorafenib resistance in hepatocellular carcinoma by upregulating miR-675","volume":"44","author":"Xu","year":"2020","journal-title":"Oncol. Rep."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"9515071","DOI":"10.1155\/2020\/9515071","article-title":"LncRNA HOTAIR Contributes to Sorafenib Resistance through Suppressing miR-217 in Hepatic Carcinoma","volume":"2020","author":"Tang","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1002\/cam4.3020","article-title":"SNGH16 regulates cell autophagy to promote Sorafenib Resistance through suppressing miR-23b-3p via sponging EGR1 in hepatocellular carcinoma","volume":"9","author":"Jing","year":"2020","journal-title":"Cancer Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1158\/1535-7163.MCT-19-0203","article-title":"Long Noncoding RNA MALAT1 Contributes to Sorafenib Resistance by Targeting miR-140-5p\/Aurora-A Signaling in Hepatocellular Carcinoma","volume":"19","author":"Fan","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.2147\/OTT.S229913","article-title":"HANR Enhances Autophagy-Associated Sorafenib Resistance Through miR-29b\/ATG9A Axis in Hepatocellular Carcinoma","volume":"13","author":"Shi","year":"2020","journal-title":"Onco Targets"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1002\/jcp.29230","article-title":"LncRNA NEAT1 promotes autophagy via regulating miR-204\/ATG3 and enhanced cell resistance to sorafenib in hepatocellular carcinoma","volume":"235","author":"Li","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1111\/jcmm.14465","article-title":"LncRNA FOXD2-AS1 as a competitive endogenous RNA against miR-150-5p reverses resistance to sorafenib in hepatocellular carcinoma","volume":"23","author":"Sui","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s13402-021-00605-0","article-title":"MT1JP-mediated miR-24-3p\/BCL2L2 axis promotes Lenvatinib resistance in hepatocellular carcinoma cells by inhibiting apoptosis","volume":"44","author":"Yu","year":"2021","journal-title":"Cell Oncol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.omto.2020.10.010","article-title":"lncRNA DUXAP8 Facilitates Multiple Malignant Phenotypes and Resistance to PARP Inhibitor in HCC via Upregulating FOXM1","volume":"19","author":"Hu","year":"2020","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"e00720","DOI":"10.1002\/prp2.720","article-title":"Upregulated UCA1 contributes to oxaliplatin resistance of hepatocellular carcinoma through inhibition of miR-138-5p and activation of AKT\/mTOR signaling pathway","volume":"9","author":"Huang","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1111\/jcmm.13605","article-title":"LncRNA NR2F1-AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC1 via miR-363","volume":"22","author":"Huang","year":"2018","journal-title":"J. Cell Mol. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11010-020-03904-6","article-title":"LncRNA MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p\/Nova1 axis","volume":"476","author":"Cao","year":"2021","journal-title":"Mol. Cell Biochem."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/jcb.29833","article-title":"Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway","volume":"122","author":"Gao","year":"2021","journal-title":"J. Cell Biochem."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1089\/dna.2019.5282","article-title":"Overexpression of Growth-Arrest-Specific Transcript 5 Improved Cisplatin Sensitivity in Hepatocellular Carcinoma Through Sponging miR-222","volume":"39","author":"Zhao","year":"2020","journal-title":"DNA Cell Biol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.omtn.2019.10.035","article-title":"LINC01234\/MicroRNA-31-5p\/MAGEA3 Axis Mediates the Proliferation and Chemoresistance of Hepatocellular Carcinoma Cells","volume":"19","author":"Chen","year":"2020","journal-title":"Mol. Ther. Nucleic. Acids"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Nishida, N. (2021). Role of Oncogenic Pathways on the Cancer Immunosuppressive Microenvironment and Its Clinical Implications in Hepatocellular Carcinoma. Cancers, 13.","DOI":"10.3390\/cancers13153666"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"6374","DOI":"10.1002\/cam4.4177","article-title":"Metabolic reprogramming of immune cells: Shaping the tumor microenvironment in hepatocellular carcinoma","volume":"10","author":"Xia","year":"2021","journal-title":"Cancer Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/JHC.S268292","article-title":"MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma","volume":"8","author":"Gramantieri","year":"2021","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Bao, M.H., and Wong, C.C. (2021). Hypoxia, Metabolic Reprogramming, and Drug Resistance in Liver Cancer. Cells, 10.","DOI":"10.3390\/cells10071715"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/CAD.0000000000001070","article-title":"Long noncoding RNA ZFPM2-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by regulating the miR-576-3p\/HIF-1\u03b1 axis","volume":"32","author":"Song","year":"2021","journal-title":"Anticancer Drugs"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.21037\/atm-20-5556","article-title":"LncRNA HULC shRNA disinhibits miR-377-5p to suppress the growth and invasion of hepatocellular carcinoma in vitro and hepatocarcinogenesis in vivo","volume":"8","author":"Yan","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13046-021-01868-z","article-title":"Long non-coding RNA MAPKAPK5-AS1\/PLAGL2\/HIF-1\u03b1 signaling loop promotes hepatocellular carcinoma progression","volume":"40","author":"Wang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3389\/fonc.2020.00998","article-title":"Hypoxia-Induced lncRNA-NEAT1 Sustains the Growth of Hepatocellular Carcinoma via Regulation of miR-199a-3p\/UCK2","volume":"10","author":"Zhang","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbrc.2019.08.039","article-title":"Hypoxia-induced lncRNA EIF3J-AS1 accelerates hepatocellular carcinoma progression via targeting miR-122-5p\/CTNND2 axis","volume":"518","author":"Yang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41419-020-2366-7","article-title":"HIF1A activates the transcription of lncRNA RAET1K to modulate hypoxia-induced glycolysis in hepatocellular carcinoma cells via miR-100-5p","volume":"11","author":"Zhou","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"109703","DOI":"10.1016\/j.biopha.2019.109703","article-title":"LncRNA HOTAIR knockdown inhibits glycolysis by regulating miR-130a-3p\/HIF1A in hepatocellular carcinoma under hypoxia","volume":"125","author":"Hu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.bbrc.2020.09.076","article-title":"Hypoxia-inducible long noncoding RNA NPSR1-AS1 promotes the proliferation and glycolysis of hepatocellular carcinoma cells by regulating the MAPK\/ERK pathway","volume":"533","author":"He","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"43588","DOI":"10.18632\/oncotarget.9635","article-title":"Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1\u03b1 activity and inhibiting epithelial-mesenchymal transition","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.omtn.2019.05.027","article-title":"Long Non-coding RNA FENDRR Acts as a miR-423-5p Sponge to Suppress the Treg-Mediated Immune Escape of Hepatocellular Carcinoma Cells","volume":"17","author":"Yu","year":"2019","journal-title":"Mol. Ther Nucleic. Acids"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"15129","DOI":"10.1038\/ncomms15129","article-title":"The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion","volume":"8","author":"Jiang","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biocel.2019.01.019","article-title":"Repression of lncRNA NEAT1 enhances the antitumor activity of CD8+T cells against hepatocellular carcinoma via regulating miR-155\/Tim-3","volume":"110","author":"Yan","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41419-018-0528-7","article-title":"Long non-coding RNA Lnc-Tim3 exacerbates CD8 T cell exhaustion via binding to Tim-3 and inducing nuclear translocation of Bat3 in HCC","volume":"9","author":"Ji","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"109738","DOI":"10.1016\/j.cellsig.2020.109738","article-title":"LncRNA TP73-AS1\/miR-539\/MMP-8 axis modulates M2 macrophage polarization in hepatocellular carcinoma via TGF-\u03b21 signaling","volume":"75","author":"Chen","year":"2020","journal-title":"Cell Signal."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s13046-021-01973-z","article-title":"Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p\/CXCL17 axis","volume":"40","author":"Wang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Li, X., Lei, Y., Wu, M., and Li, N. (2018). Regulation of Macrophage Activation and Polarization by HCC-Derived Exosomal lncRNA TUC339. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19102958"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.canlet.2019.05.019","article-title":"Individualized precision treatment: Targeting TAM in HCC","volume":"458","author":"Li","year":"2019","journal-title":"Cancer Lett."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Chung, J.Y., Chan, M.K., Li, J.S., Chan, A.S., Tang, P.C., Leung, K.T., To, K.F., Lan, H.Y., and Tang, P.M. (2021). TGF-\u03b2 Signaling: From Tissue Fibrosis to Tumor Microenvironment. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147575"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"8216541","DOI":"10.1155\/2020\/8216541","article-title":"Overexpression of NNT-AS1 Activates TGF-\u03b2 Signaling to Decrease Tumor CD4 Lymphocyte Infiltration in Hepatocellular Carcinoma","volume":"2020","author":"Wang","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4149\/neo_2020_200730N785","article-title":"LncRNA MEG8 plays an oncogenic role in hepatocellular carcinoma progression through miR-367-3p\/14-3-3\u03b6\/TGF\u03b2R1 axis","volume":"68","author":"Lou","year":"2021","journal-title":"Neoplasma"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41419-019-2188-7","article-title":"Long non-coding RNA DLGAP1-AS1 facilitates tumorigenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via the feedback loop of miR-26a\/b-5p\/IL-6\/JAK2\/STAT3 and Wnt\/\u03b2-catenin pathway","volume":"11","author":"Lin","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/hep.29405","article-title":"Long noncoding RNA TSLNC8 is a tumor suppressor that inactivates the interleukin-6\/STAT3 signaling pathway","volume":"67","author":"Zhang","year":"2018","journal-title":"Hepatology"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"C649","DOI":"10.1152\/ajpcell.00510.2018","article-title":"Long non-coding RNA MALAT1 promotes angiogenesis and immunosuppressive properties of HCC cells by sponging miR-140","volume":"318","author":"Hou","year":"2020","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Reda, E., Sayed, S., Cristante, J., Guyon, L., Denis, J., Chabre, O., and Cherradi, N. (2021). MicroRNA Therapeutics in Cancer: Current Advances and Challenges. Cancers, 13.","DOI":"10.3390\/cancers13112680"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Shi, T., Morishita, A., Kobara, H., and Masaki, T. (2021). The Role of microRNAs in Cholangiocarcinoma. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147627"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","article-title":"Noncoding RNA therapeutics\u2014Challenges and potential solutions","volume":"20","author":"Winkle","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1007\/s11033-021-06247-7","article-title":"Long non-coding RNA-based glycolysis-targeted cancer therapy: Feasibility, progression and limitations","volume":"48","author":"Liu","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S1470-2045(17)30621-6","article-title":"Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: A first-in-man, phase 1, open-label, dose-escalation study","volume":"18","author":"Pavlakis","year":"2017","journal-title":"Lancet Oncol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/19\/10630\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:08:06Z","timestamp":1760166486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/19\/10630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,30]]},"references-count":158,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["ijms221910630"],"URL":"https:\/\/doi.org\/10.3390\/ijms221910630","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,30]]}}}